Ischemic preconditioning of myocardium

Acta Pharmacologica Sinica

Volumn 23, Issue 10, 2002, Pages 865-870

  Tyagi, Priya ^a   Tayal, Girish ^a  

^a MAULANA AZAD MEDICAL COLLEGE   (India)

Author keywords

Adenosine; Ischemic preconditioning; Mitochondria; Myocardium; Nitric oxide

Indexed keywords

ADENOSINE A1 RECEPTOR; ADENOSINE TRIPHOSPHATE; BRADYKININ; BRADYKININ B2 RECEPTOR; DIPEPTIDYL CARBOXYPEPTIDASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PHOSPHOLIPASE C; PHOSPHORYL LIPID A; POTASSIUM CHANNEL; PROTEIN KINASE C; ADENOSINE; BRADYKININ RECEPTOR;

CORONARY ARTERY BYPASS SURGERY; HEART INFARCTION; HEART INFARCTION PREVENTION; HEART MUSCLE ISCHEMIA; HEART MUSCLE NECROSIS; HEART PROTECTION; HUMAN; PROTEIN EXPRESSION; REPERFUSION INJURY; REVIEW; SIGNAL TRANSDUCTION; ANIMAL; METABOLISM;

ADENOSINE; ANIMALS; BRADYKININ; HUMANS; ISCHEMIC PRECONDITIONING, MYOCARDIAL; PHOSPHOLIPASE C; PROTEIN KINASE C; RECEPTOR, BRADYKININ B2; RECEPTORS, BRADYKININ;

EID: 0036790692     PISSN: 16714083     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (37)

1. Murray CE, Jennings RB, Reimer KA. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 1986; 74: 1124-36.
2. Kuzuya T, Hoshida S, Yamashita N, Fuji H, Hori M, Kamada T, et al. Delayed effects of sublethal ischemia on the acquisition of tolerance to ischemia. Circ Res 1993; 72: 1293-9.
3. Marber MS, Latchman DS, Walker JM, Yellon DM. Cardiac stress protein elevation 24 hrs after brief ischemia or heat stress is associated with resistance to myocardial infarction. Circulation 1993; 88: 1264-72.
4. Li Y, Whittaker P, Kloner RA. The transient nature of the effect of ischemic preconditioning on myocardial infarct size and ventricular arrythmias. Am Heart J 1992; 123: 346-53.
5. Ovize M, Pryklenk K, Hale SL, Kloner RA. Preconditioning does not attenuate myocardial stunning. Circulation 1992; 85: 2247-54.
6. Nao BS, Mcclanahan TB, Groh MA, Scott RJ, Gallagher KP. The time limit of effective ischemic preconditioning in dogs. Circulation 1990; 82 (Suppl): 111-271.
7. Thornton J, Striplin S, Liu GS, Swafford A, Stanley AW, van Winkle DM, et al. Inhibition of protein synthesis does not block myocardial protection afforded by preconditioning. Am J Physiol 1990; 259: H1822-5.
8. Mullane K, Bullough D. Harnessing an endogenous cardioprotective mechanism: cellular sources and sites of action of adenosine. J Mol Cell Cardiol 1995; 27: 1041-54.
9. Banerjee A, Locke-Winter C, Rogers KB, Mitchell MB, Brew EC, Cairnsc B, et al. Preconditioning against myocardial dysfunction after ischemia and reperfusion by an alpha-1-adrenergic mechanism. Circ Res 1993; 73: 656-70.
10. Schultz JE, Hsu AK, Gross GJ. Morphine mimics the cardioprotective effect of ischemic preconditioning via a glibenclamide-sensitive mechanism in the rat heart. Circ Res 1996; 78: 1100-4.
11. Reimer KA, Murry CE, Yamasawa I, Hill ML, Jennings RB. Four brief periods of ischemia cause no cumulative ATP loss or necrosis. Am J Physiol 1986; 251: H1306-15.
12. Li YL, He RR. Protective effect of preconditioning on ischemic heart and characterization of adenosine receptors in ischemic rabbit hearts. Acta Pharmacol Sin 1995; 16: 505-8.
13. Maczewski M, Beresewicz A. The role of adenosine and ATP sensitive potassium channels in the protection afforded by ischemic preconditioning against the post ischemic endothelial dysfunction in the guinea pig hearts. J Mol Cell Cardiol 1998; 30: 1735-47.
14. 2 receptor activation. Circ Res 1997; 81: 415-22.
15. + channels in cardiac muscle. Nature 1983; 305: 147-8.
16. Trube G, Hescheler J. Inward-rectifying channels in isolated patches of the heart cell membrane: ATP-dependence and comparison with cell-attached patches. Pfluegers Arch 1984; 401: 178-84.
17. + channels and myocardial preconditioning. Circ Res 1999; 84: 973-9.
18. Grover GJ, Garlid KD. ATP-sensitive potassium channels: a review of their cardioprotective pharmacology. J Mol Cell Cardiol 2000; 88: 677-95.
19. Bouchard JF, Chouinard J, Lamontagne D. Role of kinins in the endothelial protective effect of ischemic preconditioning. Br J Pharmacol 1998; 123: 413-20.
20. Jin ZQ, Chen X. Bradykinin mediates myocardial ischemic preconditioning against free radical injury in guinea pig isolated heart. Clin Exp Pharmacol Physiol 1998; 32: 337-42.
21. Ahluwalia A, Perretti M. B1 receptors as new inflammatory target. Could this B the 1? Trends Pharmacol Sci 1999; 20: 100-4.
22. Thornton JD, Liu GS, Downey JM. Pretreatment with pertussis toxin blocks the protective effects of preconditioning; evidence of a G-protein mechanism. J Mol Cell Cardiol 1993; 25: 311-20.
23. ATP channels through activation of protein kinase C in rat ventricular myocytes. Acta Pharmacol Sin 2000; 21: 845-9
24. Dorn GW 2nd, Souroujon MC, Liron T, Chen CH, Gray MO, Zhou HZ, et al. Sustained in vivo cardiac protection by a rationally designed peptide that causes epsilon protein kinase C translocation. Proc Natl Acad Sci 1999; 96: 12798-803.
25. Fryer RM, Schultz JEJ, Hsu AK, Gross GJ. Importance of PKC and tyrosine kinase in single or multiple cycles of pre-conditioning in rat hearts. Am J Physiol 1999; 276: H1229-35.
26. Weinbrenner CJ, Liu GS, Cohen MV, Downey JM. Phosphorylation of tyrosine 182 of p38 mitogen-activated protein kinase correlates with the protection of preconditioning in rabbit heart. Mol Cell Cardiol 1997; 29: 2383-91.
27. Ping P, Zhang J, Cao X, Li RC, Kong D, Tang XL, et al. PKC dependent activation of p44/p42 MAPKs during myocardial ischemia-reperfusion in conscious rabbits. Am J Physiol 1999; 276 (5 Pt 2): H1468-81.
28. Takano H, Tang XL, Qiu Y, Guo Y, French B, Bolli R. Nitric oxide donors induce late preconditioning against myocardial stunning and infarction in conscious rabbits via an antioxidant-sensitive mechanism. Circ Res 1998; 83: 73-84.
29. Bolli R, Manchikalapudi S, Tang XL, Takano H, Qiu Y, Guo Y, et al. The protective effect of late preconditioning against myocardial stunning in conscious rabbits is mediated by nitric oxide synthase: evidence that nitric oxide acts both as a trigger and as a mediator of the late phase of preconditioning. Circ Res 1997; 81: 1094-107.
30. Xuan YT, Tang XL, Qiu Y, Banerjee S, Takano H, Han H, et al. Biphasic response of cardiac NO synthase to ischemic preconditioning in conscious rabbits. Am J Physiol 2000; 279: H2360-71.
31. Bolli R, Dawn B, Tang XL, Qiu Y, Ping P, Xuan YT, et al. The nitric oxide hypothesis of late preconditioning. Basic Res Cardiol 1998; 93: 325-38.
32. Lu R, Jun P, Ye F, Deng HW, Li YJ. Involvement of heme oxygenase-1 in delayed cardioprotection induced by monophosphoryl lipid A in rats. Acta Pharmacol Sin 2002; 23: 33-9
33. Lei XI, Kukreja RC. Pivotal role of nitric oxide in delayed pharmacological preconditioning against myocardial infarction. Toxicology 2000; 155: 37-44.
34. Baxter GF, Goma FM, Yellon DM. Involvement of protein kinase C in the delayed cytoprotection following sublethal ischemia in rabbit myocardium. Br J Pharmacol 1995; 31: 222-4.
35. Ping P, Zhang J, Zheng YT, Li RC, Dawn B, Tang XL, et al. Demonstration of selective, PKC-dependent activation of Src and Lck tyrosine kinases during ischemic preconditioning in conscious rabbits. Circ Res 1999; 85: 542-50.
36. Plumier JCL, Ross BM, Currie RW, Angelidis CE, Kazlaris H, Kollias G, et al. Transgenic mice expressing the human heat-shock protein 70 have improved post-ischemic myocardial recovery. J Clin Invest 1995; 95: 1854-60.
37. 2 receptor activation in human heart. J Am Coll Cardiol 1997; 29: 1599-606.